National Institute on Drug Abuse; Notice of Closed Meetings, 21797-21798 [2019-10064]
Download as PDF
<![CDATA[
Federal Register / Vol. 84, No. 94 / Wednesday, May 15, 2019 / Notices
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of
Closed Meetings
jbell on DSK3GLQ082PROD with NOTICES
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Vascular and
Hematology Integrated Review Group;
Molecular and Cellular Hematology Study
Section.
Date: June 10–11, 2019.
Time: 8:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Residence Inn Bethesda, 7335
Wisconsin Avenue, Bethesda, MD 20814.
Contact Person: Luis Espinoza, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 6183,
MSC 7804, Bethesda, MD 20892, 301–495–
1213, espinozala@mail.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Evaluation
and Implementation of Patient Care.
Date: June 13, 2019.
Time: 7:30 a.m. to 10:00 a.m.
Agenda: To review and evaluate grant
applications.
Place: Renaissance New Orleans Pere
Marquette, 817 Common Street, New
Orleans, LA 1855201.
Contact Person: Sheba King Dunston,
Ph.D., Scientific Review Officer, Center for
Scientific of Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3150,
Bethesda, MD 20892, dunstonsk@
mail.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Small
Business: Innovative Immunology.
Date: June 13, 2019.
Time: 8:30 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Courtyard Silver Spring Downtown,
8506 Fenton Street, Silver Spring, MD 20910.
Contact Person: David B. Winter, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4204,
MSC 7812, Bethesda, MD 20892, 301–435–
1152, dwinter@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Small
VerDate Sep<11>2014
22:43 May 14, 2019
Jkt 247001
Business: Orthopedic, Skeletal Muscle and
Oral Sciences.
Date: June 13–14, 2019.
Time: 8:30 a.m. to 10:30 a.m.
Agenda: To review and evaluate grant
applications.
Place: Bethesda North Marriott Hotel &
Conference Center, 5701 Marinelli Road,
Bethesda, MD 20852.
Contact Person: Aftab A. Ansari, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4108,
MSC 7814, Bethesda, MD 20892, 301–237–
9931, ansaria@csr.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393–93.396, 93.837–93.844,
93.846–93.878, 93.892, 93.893, National
Institutes of Health, HHS)
Dated: May 10, 2019.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2019–10059 Filed 5–14–19; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
21797
MD 20892–5452, (301) 594–7799, yangj@
extra.niddk.nih.gov.
Name of Committee: National Institute of
Diabetes and Digestive and Kidney Diseases
Special Emphasis Panel; Type 1 Diabetes
TrialNet Coordinating Center and Clinical
Network Hub (U01).
Date: June 28, 2019.
Time: 12:00 p.m. to 3:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, Two
Democracy Plaza, 6707 Democracy
Boulevard, Bethesda, MD 20892 (Telephone
Conference Call).
Contact Person: Dianne Camp, Ph.D.,
Scientific Review Officer, Review Branch,
DEA, NIDDK, National Institutes of Health,
Room 7013, 6707 Democracy Boulevard,
Bethesda, MD 20892–2542, 301–5947682,
campd@extra.niddk.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.847, Diabetes,
Endocrinology and Metabolic Research;
93.848, Digestive Diseases and Nutrition
Research; 93.849, Kidney Diseases, Urology
and Hematology Research, National Institutes
of Health, HHS)
Dated: May 10, 2019.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2019–10065 Filed 5–14–19; 8:45 am]
National Institutes of Health
BILLING CODE 4140–01–P
National Institute of Diabetes and
Digestive and Kidney Diseases; Notice
of Closed Meetings
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Diabetes and Digestive and Kidney Diseases
Special Emphasis Panel; R13 Conference
Grant Applications.
Date: June 27, 2019.
Time: 11:00 a.m. to 12:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, Two
Democracy Plaza, 6707 Democracy
Boulevard, Bethesda, MD 20892 (Telephone
Conference Call).
Contact Person: Jian Yang, Ph.D., Scientific
Review Officer, Review Branch, DEA,
NIDDK, National Institutes of Health, Room
7111, 6707 Democracy Boulevard, Bethesda,
PO 00000
Frm 00050
Fmt 4703
Sfmt 4703
National Institutes of Health
National Institute on Drug Abuse;
Notice of Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute on
Drug Abuse Special Emphasis Panel;
Exploring Epigenomic or Non-Coding RNA
Regulation in the Development,
Maintenance, or Treatment of Chronic Pain
(R61/R33 Clinical Trial Optional).
Date: May 24, 2019.
Time: 12:00 p.m. to 3:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Neuroscience Center Building (NSC), 6001
E:\FR\FM\15MYN1.SGM
15MYN1
21798
Federal Register / Vol. 84, No. 94 / Wednesday, May 15, 2019 / Notices
Executive Boulevard, Rockville, MD 20852
(Telephone Conference Call).
Contact Person: Ipolia R. Ramadan, Ph.D.,
Scientific Review Officer, Office of
Extramural Policy and Review, Division of
Extramural Research, National Institute on
Drug Abuse, NIH, DHHS, 6001 Executive
Boulevard, Room 4228, MSC 9550, Bethesda,
MD 20892, 301–827–5842, ramadanir@
mail.nih.gov.
Name of Committee: National Institute on
Drug Abuse Special Emphasis Panel; NIH
Pathway to Independence Award (K99/R00).
Date: June 5, 2019.
Time: 1:00 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Neuroscience Center Building (NSC), 6001
Executive Boulevard, Rockville, MD 20852
(Telephone Conference Call).
Contact Person: Susan O. McGuire, Ph.D.,
Scientific Review Officer, Office of
Extramural Policy and Review, National
Institute on Drug Abuse, National Institutes
of Health, DHHS, 6001 Executive Blvd.,
Room 4245, Rockville, MD 20852, (301) 827–
5817, mcguireso@mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos.: 93.279, Drug Abuse and
Addiction Research Programs, National
Institutes of Health, HHS)
Dated: May 10, 2019.
Natasha M. Copeland,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2019–10064 Filed 5–14–19; 8:45 am]
BILLING CODE 4140–01–P
The 2019 tariff-rate quota is
applicable to tuna in airtight containers
entered, or withdrawn from warehouse,
for consumption during the period
January 1, 2019 through December 31,
2019.
DATES:
Julia
Peterson, Headquarters Quota and
Agricultural Branch, Interagency
Collaboration Division, Trade Policy
and Programs, Office of Trade, U.S.
Customs and Border Protection,
Washington, DC 20229–1155, (202) 384–
8905.
FOR FURTHER INFORMATION CONTACT:
Background
It has been determined that
14,945,117 kilograms of tuna in airtight
containers may be entered, or
withdrawn from warehouse, for
consumption during Calendar Year
2019, at the rate of 6.0 percent ad
valorem under subheading 1604.14.22,
Harmonized Tariff Schedule of the
United States (HTSUS). Any such tuna
which is entered, or withdrawn from
warehouse, for consumption during the
current calendar year in excess of this
quota will be dutiable at the rate of 12.5
percent ad valorem under subheading
1604.14.30, HTSUS.
Dated: May 9, 2019.
Brenda Smith,
Executive Assistant Commissioner, Office of
Trade.
[FR Doc. 2019–10012 Filed 5–14–19; 8:45 am]
BILLING CODE 9111–14–P
DEPARTMENT OF HOMELAND
SECURITY
U.S. Customs and Border Protection
DEPARTMENT OF HOMELAND
SECURITY
[CBP Dec. 19–04]
Office of the Secretary
Determination Pursuant to Section 102
of the Illegal Immigration Reform and
Immigrant Responsibility Act of 1996,
as Amended
Tuna Tariff-Rate Quota for Calendar
Year 2019 Tuna Classifiable Under
Subheading 1604.14.22, Harmonized
Tariff Schedule of the United States
(HTSUS)
Office of the Secretary,
Department of Homeland Security.
ACTION: Notice of determination.
AGENCY:
U.S. Customs and Border
Protection, Department of Homeland
Security.
ACTION: Announcement of the quota
quantity of tuna in airtight containers
for Calendar Year 2019.
AGENCY:
Each year, the tariff-rate quota
for tuna described in subheading
1604.14.22, Harmonized Tariff Schedule
of the United States (HTSUS), is
calculated as a percentage of the tuna in
airtight containers entered, or
withdrawn from warehouse, for
consumption during the preceding
calendar year. This document sets forth
the tariff-rate quota for Calendar Year
2019.
jbell on DSK3GLQ082PROD with NOTICES
SUMMARY:
VerDate Sep<11>2014
22:43 May 14, 2019
Jkt 247001
The Secretary of Homeland
Security has determined, pursuant to
law, that it is necessary to waive certain
laws, regulations, and other legal
requirements in order to ensure the
expeditious construction of barriers and
roads in the vicinity of the international
land border in Cochise County and Pima
County, Arizona.
DATES: This determination takes effect
on May 15, 2019.
SUPPLEMENTARY INFORMATION: Important
mission requirements of the Department
of Homeland Security (‘‘DHS’’) include
border security and the detection and
SUMMARY:
PO 00000
Frm 00051
Fmt 4703
Sfmt 4703
prevention of illegal entry into the
United States. Border security is critical
to the nation’s national security.
Recognizing the critical importance of
border security, Congress has mandated
DHS to achieve and maintain
operational control of the international
land border. Secure Fence Act of 2006,
Public Law 109–367, 2, 120 Stat. 2638
(Oct. 26, 2006) (8 U.S.C. 1701 note).
Congress defined ‘‘operational control’’
as the prevention of all unlawful entries
into the United States, including entries
by terrorists, other unlawful aliens,
instruments of terrorism, narcotics, and
other contraband. Id. Consistent with
that mandate from Congress, the
President’s Executive Order on Border
Security and Immigration Enforcement
Improvements directed executive
departments and agencies to deploy all
lawful means to secure the southern
border. Executive Order 13767, § 1. In
order to achieve that end, the President
directed, among other things, that I take
immediate steps to prevent all unlawful
entries into the United States, including
the immediate construction of physical
infrastructure to prevent illegal entry.
Executive Order 13767, § 4(a).
Congress has provided to the
Secretary of Homeland Security a
number of authorities necessary to carry
out DHS’s border security mission. One
of those authorities is section 102 of the
Illegal Immigration Reform and
Immigrant Responsibility Act of 1996,
as amended (‘‘IIRIRA’’). Public Law
104–208, Div. C, 110 Stat. 3009–546,
3009–554 (Sept. 30, 1996) (8 U.S.C 1103
note), as amended by the REAL ID Act
of 2005, Public Law 109–13, Div. B, 119
Stat. 231, 302, 306 (May 11, 2005) (8
U.S.C. 1103 note), as amended by the
Secure Fence Act of 2006, Public Law
109–367, 3, 120 Stat. 2638 (Oct. 26,
2006) (8 U.S.C. 1103 note), as amended
by the Department of Homeland
Security Appropriations Act, 2008,
Public Law 110–161, Div. E, Title V,
§ 564, 121 Stat. 2090 (Dec. 26, 2007). In
section 102(a) of IIRIRA, Congress
provided that the Secretary of
Homeland Security shall take such
actions as may be necessary to install
additional physical barriers and roads
(including the removal of obstacles to
detection of illegal entrants) in the
vicinity of the United States border to
deter illegal crossings in areas of high
illegal entry into the United States. In
section 102(b) of IIRIRA, Congress
mandated the installation of additional
fencing, barriers, roads, lighting,
cameras, and sensors on the southwest
border. Finally, in section 102(c) of
IIRIRA, Congress granted to the
Secretary of Homeland Security the
E:\FR\FM\15MYN1.SGM
15MYN1
]]>Agencies
[Federal Register Volume 84, Number 94 (Wednesday, May 15, 2019)]
[Notices]
[Pages 21797-21798]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2019-10064]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute on Drug Abuse; Notice of Closed Meetings
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended, notice is hereby given of the following meetings.
The meetings will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Institute on Drug Abuse Special
Emphasis Panel; Exploring Epigenomic or Non-Coding RNA Regulation in
the Development, Maintenance, or Treatment of Chronic Pain (R61/R33
Clinical Trial Optional).
Date: May 24, 2019.
Time: 12:00 p.m. to 3:30 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Neuroscience Center
Building (NSC), 6001
[[Page 21798]]
Executive Boulevard, Rockville, MD 20852 (Telephone Conference
Call).
Contact Person: Ipolia R. Ramadan, Ph.D., Scientific Review
Officer, Office of Extramural Policy and Review, Division of
Extramural Research, National Institute on Drug Abuse, NIH, DHHS,
6001 Executive Boulevard, Room 4228, MSC 9550, Bethesda, MD 20892,
301-827-5842, [email protected].
Name of Committee: National Institute on Drug Abuse Special
Emphasis Panel; NIH Pathway to Independence Award (K99/R00).
Date: June 5, 2019.
Time: 1:00 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Neuroscience Center
Building (NSC), 6001 Executive Boulevard, Rockville, MD 20852
(Telephone Conference Call).
Contact Person: Susan O. McGuire, Ph.D., Scientific Review
Officer, Office of Extramural Policy and Review, National Institute
on Drug Abuse, National Institutes of Health, DHHS, 6001 Executive
Blvd., Room 4245, Rockville, MD 20852, (301) 827-5817,
[email protected].
(Catalogue of Federal Domestic Assistance Program Nos.: 93.279, Drug
Abuse and Addiction Research Programs, National Institutes of
Health, HHS)
Dated: May 10, 2019.
Natasha M. Copeland,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2019-10064 Filed 5-14-19; 8:45 am]
BILLING CODE 4140-01-P
